Biomarker Data From Phase II Randomized Trial  Study of Atezolizumab With or Without Bevacizumab v Sunitinib

Biomarker Data From Phase II Randomized Trial Study of Atezolizumab With or Without Bevacizumab v Sunitinib

User Photo
kidneycancer

2 years
29 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Walter M. Stadler, MD University of Chicago, discusses Biomarker Data From Phase II Randomized Trial Study of Atezolizumab With or Without Bevacizumab v Sunitinib at Kidney Cancer Association 2017 in Miami.
Up Next Autoplay
>